Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.98 USD | -0.01% |
|
-1.81% | +16.91% |
05:54am | Wolfe Research Adjusts Price Target on Gilead Sciences to $135 From $115 | MT |
06-19 | Global markets live: Microsoft, Gilead Sciences, Ford Motor, Vodafone, UBS… | ![]() |
Chart calendar Gilead Sciences, Inc.
edf19f01d3e81d61d.sBCazealZr4wicJHGHtYdJpP8G4I72FTiTKSsV1jtbA.iXbP_LzOMvtE0KVzaRESFf8smV1bsC4L3wHq5DcR-YLfKOKZregg8lP6-g~08c9243633df637b16bf82e1fcd68547
Upcoming events on Gilead Sciences, Inc.
Past events on Gilead Sciences, Inc.
Past dividends on Gilead Sciences, Inc.
2025-06-12 | Quarterly 0.79 USD |
2025-03-13 | Quarterly 0.79 USD |
2024-12-12 | Quarterly 0.77 USD |
2024-09-12 | Quarterly 0.77 USD |
2024-06-13 | Quarterly 0.77 USD |
2024-03-13 | Quarterly 0.77 USD |
2023-12-13 | Quarterly 0.75 USD |
2023-09-13 | Quarterly 0.75 USD |
2023-06-13 | Quarterly 0.75 USD |
2023-03-13 | Quarterly 0.75 USD |
2022-12-13 | Quarterly 0.73 USD |
2022-09-13 | Quarterly 0.73 USD |
2022-06-13 | Quarterly 0.73 USD |
2022-03-13 | Quarterly 0.73 USD |
2021-12-13 | Quarterly 0.71 USD |
2021-09-13 | Quarterly 0.71 USD |
2021-06-13 | Quarterly 0.71 USD |
2021-03-11 | Quarterly 0.71 USD |
2020-12-13 | Quarterly 0.68 USD |
2020-09-13 | Quarterly 0.68 USD |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 27 281 26 518 2.88% | 27 116 27 083 0.12% | 28 754 28 310 1.57% | 28 675 | 29 749 | 31 253 |
EBITDA Million USD | Released Forecast Spread | 14 283 13 783 3.63% | 13 177 13 123 0.41% | 11 287 10 600 6.49% | 15 708 | 16 209 | 17 328 |
EBIT Million USD | Released Forecast Spread | 12 180 12 141 0.32% | 10 484 10 687 -1.9% | 8 520 8 238 3.42% | 13 005 | 13 710 | 14 560 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 814 5 658 2.76% | 6 859 7 323 -6.33% | 690 498 38.57% | 9 181 | 10 370 | 11 038 |
Net income Million USD | Released Forecast Spread | 4 592 4 383 4.77% | 5 665 5 872 -3.52% | 480 282 70.44% | 7 432 | 8 466 | 9 243 |
EPS USD | Released Forecast Spread | 3,64 3,48 4.75% | 4,50 4,69 -3.96% | 0,38 0,10 274.46% | 6,03 | 6,87 | 7,49 |
Announcement Date | 02/02/23 | 06/02/24 | 11/02/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7 051 6 800 3.69% | 7 115 7 104 0.16% | 6 686 6 349 5.31% | 6 954 6 735 3.25% | 7 545 6 999 7.8% | 7 569 7 154 5.8% | 6 667 6 813 -2.14% | 6 954 | 7 395 | 7 576 | 6 958 | 7 201 | 7 623 | 7 983 |
EBITDA Million USD | Released Forecast Spread | 3 908 3 636 7.49% | 3 427 3 495 -1.94% | -427 -889 51.98% | 3 959 3 365 17.67% | 3 948 3 498 12.86% | 3 807 3 255 16.94% | 3 589 3 423 4.85% | 3 997 | 4 211 | 4 171 | 3 852 | 4 029 | 4 349 | 4 360 |
EBIT Million USD | Released Forecast Spread | 3 224 3 060 5.37% | 2 739 2 940 -6.84% | -1 117 -1 679 33.48% | 3 265 2 739 19.18% | 3 258 2 721 19.75% | 3 114 2 876 8.27% | 2 893 2 830 2.22% | 3 199 | 3 540 | 3 371 | 3 145 | 3 284 | 3 609 | 3 808 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 318 2 275 1.91% | 1 653 2 090 -20.89% | -4 486 | 2 053 1 733 18.45% | 956 1 652 -42.12% | 2 168 2 043 6.14% | 1 649 2 068 -20.24% | 2 334 | 2 713 | 2 503 | 2 507 | 2 701 | 3 139 | 2 823 |
Net income Million USD | Released Forecast Spread | 2 180 1 801 21.07% | 1 429 1 599 -10.66% | -4 170 -2 888 -44.38% | 1 614 1 379 17.02% | 1 253 1 335 -6.15% | 1 783 1 605 11.1% | 1 315 1 533 -14.2% | 1 881 | 2 148 | 2 066 | 1 961 | 2 113 | 2 406 | 2 280 |
EPS USD | Released Forecast Spread | 1,73 1,43 20.88% | 1,14 1,28 -11.05% | -3,34 -1,92 -74.06% | 1,29 1,13 14.13% | 1,00 1,08 -7.48% | 1,42 1,19 19.08% | 1,04 1,26 -17.75% | 1,47 | 1,72 | 1,65 | 1,48 | 1,62 | 1,85 | 1,81 |
Announcement Date | 07/11/23 | 06/02/24 | 25/04/24 | 08/08/24 | 06/11/24 | 11/02/25 | 24/04/25 | - | - | - | - | - | - | - |
More events
Past sector events for Gilead Sciences, Inc.
2025-06-17 11:45 | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-09 04:48 | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
2025-06-08 20:01 | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-06 04:47 | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-05 04:37 | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
2025-06-03 04:35 | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
2025-05-30 09:46 | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release |
2025-05-29 07:00 | ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release |
2025-05-29 04:31 | ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- Calendar Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition